Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
Clinical trial NCT07097207 · RECRUITING
Trial details
- NCT number
- NCT07097207
- Sponsor
- Shenzhen University General Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2026-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.